People
Becky Kaufman specializes in the development, procurement and commercial exploitation of patent rights. A partner in our Intellectual Property Counseling practice, Becky counsels public and private companies, investors and research organizations, primarily in the life sciences, industrial biotechnology and chemical industries.
Becky regularly structures and negotiates a wide range of IP-based commercial and strategic transactions, including licensing and collaboration deals as well as research and development, material transfer, manufacturing, supply and distribution agreements. She also represents clients in U.S. and international patent procurement, adversarial proceedings and transactional due diligence, including both established and emerging companies. Becky brings pragmatic business experience and solid technical credentials to her practice.
Prior to joining the firm, Becky was a principal with Cordova Ventures, an early stage venture capital fund. She also previously worked for the Georgia Institute of Technology's Advanced Technology Development Center, recognized as one of nation's top technology incubators. In both roles, Becky counseled start-ups on a variety of business and intellectual property issues. She is active in the life sciences community and has served in leadership roles with several state and regional organizations.
Becky has been recognized as an IP Star by Managing Intellectual Property from 2013 through 2019. Intellectual Property Asset Management describes her commercial IP credentials as "some of the best in the business."
J.D., University of Pittsburgh
B.S., Wake Forest University
Georgia
October 5, 2021
LMG Life Sciences Recognizes King & Spalding With Multiple Rankings in its 2021 Guide
August 2, 2021
Managing IP Again Recommends Multiple King & Spalding IP Practices, Individuals in its Annual Guide
June 17, 2020
King & Spalding IP Practices and Individuals Recognized in the IAM Patent 1000 Guide
Advised Arbor Pharmaceuticals, Inc., as IP counsel in connection with its $476 million acquisition of XenoPort, Inc.
Represents Revivicor, Inc. (a subsidiary of United Therapeutics) in client counseling and development of its patent portfolio relating to genetically modified porcine for xenotransplanation.
Represents Nitto Denko Corporation in U.S. and international prosecution of its enhanced transdermal drug-delivery portfolio.
See more
April 10, 2020
COVID-19 – Take Action Now to Protect Intellectual Property Rights During Bankruptcy
January 25, 2017
International Food Law Gazette - January 2017
October 5, 2021
LMG Life Sciences Recognizes King & Spalding With Multiple Rankings in its 2021 Guide
August 2, 2021
Managing IP Again Recommends Multiple King & Spalding IP Practices, Individuals in its Annual Guide
June 17, 2020
King & Spalding IP Practices and Individuals Recognized in the IAM Patent 1000 Guide
Advised Arbor Pharmaceuticals, Inc., as IP counsel in connection with its $476 million acquisition of XenoPort, Inc.
Represents Revivicor, Inc. (a subsidiary of United Therapeutics) in client counseling and development of its patent portfolio relating to genetically modified porcine for xenotransplanation.
Represents Nitto Denko Corporation in U.S. and international prosecution of its enhanced transdermal drug-delivery portfolio.
See more
April 10, 2020
COVID-19 – Take Action Now to Protect Intellectual Property Rights During Bankruptcy
January 25, 2017
International Food Law Gazette - January 2017
October 5, 2021
LMG Life Sciences Recognizes King & Spalding With Multiple Rankings in its 2021 Guide
August 2, 2021
Managing IP Again Recommends Multiple King & Spalding IP Practices, Individuals in its Annual Guide
June 17, 2020
King & Spalding IP Practices and Individuals Recognized in the IAM Patent 1000 Guide
J.D., University of Pittsburgh
B.S., Wake Forest University
Georgia